Sara A. Courtneidge
Affiliations: | Molecular Pathology | University of California, San Diego, La Jolla, CA |
Area:
Cell Biology, BiochemistryGoogle:
"Sara Courtneidge"
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Iizuka S, Quintavalle M, Navarro JC, et al. (2021) Serine-threonine kinase TAO3-mediated trafficking of endosomes containing the invadopodia scaffold TKS5α promotes cancer invasion and tumor growth. Cancer Research |
Iizuka S, Leon RP, Gribbin KP, et al. (2020) Crosstalk between invadopodia and the extracellular matrix. European Journal of Cell Biology. 99: 151122 |
Gast CE, Silk AD, Zarour L, et al. (2018) Cell fusion potentiates tumor heterogeneity and reveals circulating hybrid cells that correlate with stage and survival. Science Advances. 4: eaat7828 |
Ouyang X, Barling A, Lesch A, et al. (2018) Induction of anaplastic lymphoma kinase (ALK) as a novel mechanism of EGFR inhibitor resistance in head and neck squamous cell carcinoma patient-derived models. Cancer Biology & Therapy. 1-37 |
Saini P, Courtneidge SA. (2018) Tks adaptor proteins at a glance. Journal of Cell Science. 131 |
Abdullah C, Korkaya H, Iizuka S, et al. (2017) SRC increases MYC mRNA expression in ER+ breast cancer via mRNA stabilization and inhibition of p53 function. Molecular and Cellular Biology |
Paterson EK, Courtneidge SA. (2017) Invadosomes are coming: new insights into function and disease relevance. The Febs Journal |
Eckert MA, Santiago-Medina M, Lwin TM, et al. (2017) ADAM12 induction by TWIST1 promotes tumor invasion and metastasis via regulation of invadopodia and focal adhesions. Journal of Cell Science |
Ouyang X, Barling A, Lesch A, et al. (2017) Abstract 78: Inhibiting anaplastic lymphoma kinase (ALK) overcomes epidermal growth factor receptor (EGFR) inhibitor resistance in head and neck squamous cell carcinoma (HNSCC) patient-derived models Clinical Cancer Research. 23: 78-78 |
Ouyang X, Barling A, Lesch A, et al. (2017) Abstract 1212: Co-targeting epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase overcomes EGFR inhibitor resistance in head and neck squamous cell carcinoma patient-derived models Cancer Research. 77: 1212-1212 |